Poralla T, Hütteroth T H, Staritz M, Meyer zum Büschenfelde K H
Z Gastroenterol. 1985 Apr;23(4):183-7.
Cellular cytotoxicity of peripheral blood lymphocytes against autologous hepatocytes was studied in 9 patients with HBeAg positive and 8 patients with anti-HBe positive chronic hepatitis B. In the HBeAg positive group a greatly increased cytotoxicity of 41 +/- 7% (mean +/- SEM) was found, in contrast the moderately increased cytotoxicity in anti-HBe positive cases of 15 +/- 5% was clearly different (p = 0.005). The different cytotoxicity values could not be explained on the basis of the histological classification, but seemed to correlate at least to some degree to the aminotransferase levels. The cytotoxic activity resided in both T cell and non-T cell enriched lymphocyte compartments. Our findings may provide an explanation for the poor prognosis of HBeAg positive patients with chronic hepatitis B in contrast to their anti-HBe positive counterparts.
对9例HBeAg阳性和8例抗-HBe阳性的慢性乙型肝炎患者外周血淋巴细胞对自体肝细胞的细胞毒性进行了研究。在HBeAg阳性组中,发现细胞毒性显著增加,为41±7%(平均值±标准误),相比之下,抗-HBe阳性病例中细胞毒性中度增加,为15±5%,两者明显不同(p = 0.005)。不同的细胞毒性值无法根据组织学分类来解释,但似乎至少在一定程度上与转氨酶水平相关。细胞毒性活性存在于T细胞和非T细胞富集的淋巴细胞亚群中。我们的研究结果可能为HBeAg阳性慢性乙型肝炎患者与其抗-HBe阳性对应患者相比预后较差提供了一种解释。